579 related articles for article (PubMed ID: 22182853)
1. Pivotal role of paracrine effects in stem cell therapies in regenerative medicine: can we translate stem cell-secreted paracrine factors and microvesicles into better therapeutic strategies?
Ratajczak MZ; Kucia M; Jadczyk T; Greco NJ; Wojakowski W; Tendera M; Ratajczak J
Leukemia; 2012 Jun; 26(6):1166-73. PubMed ID: 22182853
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic potential of mesenchymal stem cell-derived microvesicles.
Biancone L; Bruno S; Deregibus MC; Tetta C; Camussi G
Nephrol Dial Transplant; 2012 Aug; 27(8):3037-42. PubMed ID: 22851627
[TBL] [Abstract][Full Text] [Related]
3. Role of stem-cell-derived microvesicles in the paracrine action of stem cells.
Camussi G; Deregibus MC; Cantaluppi V
Biochem Soc Trans; 2013 Feb; 41(1):283-7. PubMed ID: 23356298
[TBL] [Abstract][Full Text] [Related]
4. New advances in stem cell research: practical implications for regenerative medicine.
Ratajczak MZ; Jadczyk T; Pędziwiatr D; Wojakowski W
Pol Arch Med Wewn; 2014; 124(7-8):417-26. PubMed ID: 24956404
[TBL] [Abstract][Full Text] [Related]
5. Regenerative medicine for the treatment of heart disease.
Hansson EM; Lendahl U
J Intern Med; 2013 Mar; 273(3):235-45. PubMed ID: 23331408
[TBL] [Abstract][Full Text] [Related]
6. Paracrine proangiopoietic effects of human umbilical cord blood-derived purified CD133+ cells--implications for stem cell therapies in regenerative medicine.
Ratajczak J; Kucia M; Mierzejewska K; Marlicz W; Pietrzkowski Z; Wojakowski W; Greco NJ; Tendera M; Ratajczak MZ
Stem Cells Dev; 2013 Feb; 22(3):422-30. PubMed ID: 23003001
[TBL] [Abstract][Full Text] [Related]
7. Stem cells: a revolution in therapeutics-recent advances in stem cell biology and their therapeutic applications in regenerative medicine and cancer therapies.
Mimeault M; Hauke R; Batra SK
Clin Pharmacol Ther; 2007 Sep; 82(3):252-64. PubMed ID: 17671448
[TBL] [Abstract][Full Text] [Related]
8. Paracrine/endocrine mechanism of stem cells on kidney repair: role of microvesicle-mediated transfer of genetic information.
Camussi G; Deregibus MC; Tetta C
Curr Opin Nephrol Hypertens; 2010 Jan; 19(1):7-12. PubMed ID: 19823086
[TBL] [Abstract][Full Text] [Related]
9. The renal (myo-)fibroblast: a heterogeneous group of cells.
Boor P; Floege J
Nephrol Dial Transplant; 2012 Aug; 27(8):3027-36. PubMed ID: 22851626
[TBL] [Abstract][Full Text] [Related]
10. Umbilical cord blood-derived very small embryonic like stem cells (VSELs) as a source of pluripotent stem cells for regenerative medicine.
Ratajczak MZ; Suszynska M; Pedziwiatr D; Mierzejewska K; Greco NJ
Pediatr Endocrinol Rev; 2012 Mar; 9(3):639-43. PubMed ID: 22523831
[TBL] [Abstract][Full Text] [Related]
11. Evolution and future prospects of adipose-derived immunomodulatory cell therapeutics.
McIntosh KR; Frazier T; Rowan BG; Gimble JM
Expert Rev Clin Immunol; 2013 Feb; 9(2):175-84. PubMed ID: 23390948
[TBL] [Abstract][Full Text] [Related]
12. Microvesicles derived from human adult mesenchymal stem cells protect against ischaemia-reperfusion-induced acute and chronic kidney injury.
Gatti S; Bruno S; Deregibus MC; Sordi A; Cantaluppi V; Tetta C; Camussi G
Nephrol Dial Transplant; 2011 May; 26(5):1474-83. PubMed ID: 21324974
[TBL] [Abstract][Full Text] [Related]
13. Pluripotent stem cell-based heart regeneration: from the developmental and immunological perspectives.
Lui KO; Bu L; Li RA; Chan CW
Birth Defects Res C Embryo Today; 2012 Mar; 96(1):98-108. PubMed ID: 22457181
[TBL] [Abstract][Full Text] [Related]
14. The use of stem cells in kidney disease.
Chhabra P; Brayman KL
Curr Opin Organ Transplant; 2009 Feb; 14(1):72-8. PubMed ID: 19337150
[TBL] [Abstract][Full Text] [Related]
15. Prospects for stem cell-based therapy.
Daley GQ; Scadden DT
Cell; 2008 Feb; 132(4):544-8. PubMed ID: 18295571
[TBL] [Abstract][Full Text] [Related]
16. Stem cell therapy for ischemic heart disease: where are we?
LaPar DJ; Kron IL; Yang Z
Curr Opin Organ Transplant; 2009 Feb; 14(1):79-84. PubMed ID: 19337151
[TBL] [Abstract][Full Text] [Related]
17. Stem cell therapy for end-stage heart failure: indispensable role for the cell?
Vrijsen KR; Chamuleau SA; Noort WA; Doevendans PA; Sluijter JP
Curr Opin Organ Transplant; 2009 Oct; 14(5):560-5. PubMed ID: 19623073
[TBL] [Abstract][Full Text] [Related]
18. Concise review: Adipose-derived stem cells as a novel tool for future regenerative medicine.
Mizuno H; Tobita M; Uysal AC
Stem Cells; 2012 May; 30(5):804-10. PubMed ID: 22415904
[TBL] [Abstract][Full Text] [Related]
19. Very small embryonic-like stem cells with maximum regenerative potential get discarded during cord blood banking and bone marrow processing for autologous stem cell therapy.
Bhartiya D; Shaikh A; Nagvenkar P; Kasiviswanathan S; Pethe P; Pawani H; Mohanty S; Rao SG; Zaveri K; Hinduja I
Stem Cells Dev; 2012 Jan; 21(1):1-6. PubMed ID: 21780911
[TBL] [Abstract][Full Text] [Related]
20. Regenerative medicine strategies.
Atala A
J Pediatr Surg; 2012 Jan; 47(1):17-28. PubMed ID: 22244387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
